Article ; Online: Antioxidant Cardioprotection against Reperfusion Injury: Potential Therapeutic Roles of Resveratrol and Quercetin.
Molecules (Basel, Switzerland)
2022 Volume 27, Issue 8
Abstract: Ischemia-reperfusion myocardial damage is a paradoxical tissue injury occurring during percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) patients. Although this damage could account for up to 50% of the final infarct size, ... ...
Abstract | Ischemia-reperfusion myocardial damage is a paradoxical tissue injury occurring during percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) patients. Although this damage could account for up to 50% of the final infarct size, there has been no available pharmacological treatment until now. Oxidative stress contributes to the underlying production mechanism, exerting the most marked injury during the early onset of reperfusion. So far, antioxidants have been shown to protect the AMI patients undergoing PCI to mitigate these detrimental effects; however, no clinical trials to date have shown any significant infarct size reduction. Therefore, it is worthwhile to consider multitarget antioxidant therapies targeting multifactorial AMI. Indeed, this clinical setting involves injurious effects derived from oxygen deprivation, intracellular pH changes and increased concentration of cytosolic Ca |
---|---|
MeSH term(s) | Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Humans ; Myocardial Infarction/drug therapy ; Myocardial Infarction/pathology ; Myocardial Reperfusion Injury/drug therapy ; Myocardial Reperfusion Injury/pathology ; Myocardial Reperfusion Injury/prevention & control ; Percutaneous Coronary Intervention/adverse effects ; Quercetin/pharmacology ; Quercetin/therapeutic use ; Reperfusion Injury/drug therapy ; Resveratrol/pharmacology ; Resveratrol/therapeutic use |
Chemical Substances | Antioxidants ; Quercetin (9IKM0I5T1E) ; Resveratrol (Q369O8926L) |
Language | English |
Publishing date | 2022-04-15 |
Publishing country | Switzerland |
Document type | Journal Article ; Review |
ZDB-ID | 1413402-0 |
ISSN | 1420-3049 ; 1431-5165 ; 1420-3049 |
ISSN (online) | 1420-3049 |
ISSN | 1431-5165 ; 1420-3049 |
DOI | 10.3390/molecules27082564 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.MO 81: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.